SEC EDGAR filings, ownership reports, and insider transactions for CANTEX PHARMACEUTICALS, INC..
Recent SEC filings for CANTEX PHARMACEUTICALS, INC. including SC 13G/A, 4, 3/A and more.
| Form type | Document | Filing | Description | Filing date | Reporting date | File number(s) |
|---|---|---|---|---|---|---|
| SC 13G/A | Open SC 13G/A document | View SEC filing for SC 13G/A | SC 13G/A | 03 Feb 2022 | ||
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 16 Sep 2021 | 14 Sep 2021 | 001-35867 |
| 3/A | Open 3/A document | View SEC filing for 3/A | FORM 3/A SUBMISSION | 07 Aug 2019 | 29 Jul 2019 | 001-35867 |
| SC 13G | Open SC 13G document | View SEC filing for SC 13G | SC 13G | 06 Aug 2019 | ||
| 3 | Open 3 document | View SEC filing for 3 | FORM 3 SUBMISSION | 06 Aug 2019 | 26 Jul 2019 | 001-35867 |
| D/A | Open D/A document | View SEC filing for D/A | 23 Apr 2014 | 021-192030 | ||
| D/A | Open D/A document | View SEC filing for D/A | 31 Oct 2013 | 021-192030 | ||
| D | Open D document | View SEC filing for D | 19 Feb 2013 | 021-192030 | ||
| D | Open D document | View SEC filing for D | 04 Aug 2010 | 021-145926 |
CANTEX PHARMACEUTICALS, INC. files with the SEC under CIK 0001374961. This page aggregates EDGAR filings and related ownership activity.
Industry: Pharmaceutical Preparations.